CEO INTERVIEW: Nanobodies & Breakthroughs: Scinai's Psoriasis Revolution

Dive into the cutting-edge world of biopharmaceuticals with Amir Reichman, CEO of Scinai Immunotherapeutics (NASDAQ: SCNI).

Hosted by Carmel Fisher, we discover how their innovative nanobody technology is transforming psoriasis treatment, making it more accessible and effective.

Learn about strategic partnerships, regulatory wins, and the future of personalized medicine in this exciting industry shakeup.

Relat ...